Cargando…

Soluble ST2 in coronary artery disease: Clinical biomarkers and treatment guidance

The IL-33/ST2 L signaling pathway is involved in the pathophysiological processes of several diseases and mainly exerts anti-inflammatory and antifibrotic effects. Soluble suppression of tumorigenicity 2 (sST2), which serves as a competitive inhibitory molecule of this pathway, is a member of the in...

Descripción completa

Detalles Bibliográficos
Autores principales:	Zhang, Junyan, Chen, Zhongxiu, Ma, Min, He, Yong
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	Frontiers Media S.A. 2022
Materias:	Cardiovascular Medicine
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9548599/ https://www.ncbi.nlm.nih.gov/pubmed/36225958 http://dx.doi.org/10.3389/fcvm.2022.924461

Ejemplares similares

Elevated Serum Levels of Soluble ST2 Are Associated With Plaque Vulnerability in Patients With Non-ST-Elevation Acute Coronary Syndrome
por: Luo, Guqing, et al.
Publicado: (2021)

The relationship between soluble lymphocyte activation gene-3 and coronary artery disease
por: Xiong, Xinlin, et al.
Publicado: (2022)

Serum Soluble ST2 Is a Valuable Prognostic Biomarker in Patients With Acute Heart Failure
por: Wang, Zeyu, et al.
Publicado: (2022)

Machine learning models of clinically relevant biomarkers for the prediction of stable obstructive coronary artery disease
por: Kim, Juntae, et al.
Publicado: (2022)

Case report: Spontaneous coronary artery dissection in a man with Ehlers–Danlos syndrome
por: Li, Qiao, et al.
Publicado: (2022)

Editorial: Intracoronary Imaging Guidance for Percutaneous Coronary Interventions
por: Caiazzo, Gianluca, et al.
Publicado: (2022)

Immune-related potential biomarkers and therapeutic targets in coronary artery disease
por: Liu, Chaosheng, et al.
Publicado: (2023)

IL-33/ST2 immunobiology in coronary artery disease: A systematic review and meta-analysis
por: Liu, Renli, et al.
Publicado: (2022)

Soluble programmed cell death-ligand 1 as a new potential biomarker associated with acute coronary syndrome
por: Li, Shuping, et al.
Publicado: (2022)

Soluble Platelet Release Factors as Biomarkers for Cardiovascular Disease
por: Baidildinova, Gaukhar, et al.
Publicado: (2021)

Effect of Alirocumab on Coronary Calcification in Patients With Coronary Artery Disease
por: Gao, Fei, et al.
Publicado: (2022)

Case report: Surgical repair of congenitally corrected transposition of the great arteries with the guidance of three-dimensional printing
por: Zhang, Yanchun, et al.
Publicado: (2023)

Development and validation of a nomogram for predicting significant coronary artery stenosis in suspected non-ST-segment elevation acute coronary artery syndrome with low-to-intermediate risk stratification
por: Chen, Meixiang, et al.
Publicado: (2022)

The Diagnostic Value of Soluble ST2 in Heart Failure: A Meta-Analysis
por: Yang, Chaojun, et al.
Publicado: (2021)

Intracoronary artery retrograde thrombolysis for ST-segment elevation myocardial infarction with a tortuous coronary artery: A case report and review of the literature
por: Shen, Mingzhi, et al.
Publicado: (2022)

Biomarkers in Coronary Artery Bypass Surgery: Ready for Prime Time and Outcome Prediction?
por: Parolari, Alessandro, et al.
Publicado: (2016)

Traditional Chinese Medicine for Coronary Artery Disease Treatment: Clinical Evidence From Randomized Controlled Trials
por: Liang, Bo, et al.
Publicado: (2021)

Early vascular healing after neXt-generation drug-eluting stent implantation in Patients with non-ST Elevation acute Coronary syndrome based on optical coherence Tomography guidance and evaluation (EXPECT): study protocol for a randomized controlled trial
por: Zhu, Yong-Xiang, et al.
Publicado: (2023)

Coronary Artery Bypass Grafting Versus Percutaneous Coronary Intervention for Multivessel Coronary Artery Disease: A One-Stage Meta-Analysis
por: Chew, Nicholas W. S., et al.
Publicado: (2022)

Prognostic Value of GRACE Risk Scores in Patients With Non-ST-Elevation Myocardial Infarction With Non-obstructive Coronary Arteries
por: Yin, Guoqing, et al.
Publicado: (2021)

Selecting patients with non-ST-elevation acute coronary syndrome for coronary angiography: a nationwide clinical vignette study in the Netherlands
por: Engel, Josien, et al.
Publicado: (2017)

The atherogenic index of plasma (AIP) is a predictor for the severity of coronary artery disease
por: Li, Ya, et al.
Publicado: (2023)

Clinical outcomes of percutaneous coronary intervention for de novo lesions in small coronary arteries: A systematic review and network meta-analysis
por: Ma, Wen-Rui, et al.
Publicado: (2022)

Prognostic value of soluble ST2 in AL and TTR cardiac amyloidosis: a multicenter study
por: Nicol, Martin, et al.
Publicado: (2023)

Interaction Between Treatment and Age or Sex in Non-ST-Segment Elevation Acute Coronary Disease and Three-Vessel Disease
por: Li, Tianyu, et al.
Publicado: (2022)

Case report: Acute ST-elevation myocardial infarction and cardiogenic shock caused by a giant right sinus of Valsalva aneurysm and right coronary artery compression
por: Ma, Lianyue, et al.
Publicado: (2022)

Knowledge of Hyperemic Myocardial Blood Flow in Healthy Subjects Helps Identify Myocardial Ischemia in Patients With Coronary Artery Disease
por: Lyu, Lijuan, et al.
Publicado: (2022)

Associations between pentraxin 3 and severity of coronary artery disease
por: Liu, Hua, et al.
Publicado: (2015)

Association of coronary dominance with the severity of coronary artery disease: a cross-sectional study in Shaanxi Province, China
por: Yan, Bin, et al.
Publicado: (2018)

Revascularization vs. Conservative Medical Treatment in Patients With Chronic Kidney Disease and Coronary Artery Disease: A Meta-Analysis
por: Liao, Guang-zhi, et al.
Publicado: (2022)

PPARγ Gene Polymorphisms, Metabolic Disorders, and Coronary Artery Disease
por: Song, Yongyan, et al.
Publicado: (2022)

Association Between Serum Galectin-3 Levels and Coronary Stenosis Severity in Patients With Coronary Artery Disease
por: Li, Mingxing, et al.
Publicado: (2022)

Coronary Revascularization in Patients With Stable Coronary Artery Disease: The Role of Imaging
por: Neglia, Danilo, et al.
Publicado: (2021)

One-Stop Hybrid Coronary Revascularization Versus Off-Pump Coronary Artery Bypass Grafting in Patients With Multivessel Coronary Artery Disease
por: Li, Dongjie, et al.
Publicado: (2021)

Effects of Oral Drugs on Coronary Microvascular Function in Patients Without Significant Stenosis of Epicardial Coronary Arteries: A Systematic Review and Meta-Analysis of Coronary Flow Reserve
por: Yong, Jingwen, et al.
Publicado: (2020)

Effect of Shenfu Injection on Reperfusion Injury in Patients Undergoing Primary Percutaneous Coronary Intervention for ST Segment Elevation Myocardial Infarction: A Pilot Randomized Clinical Trial
por: Wang, Xiao, et al.
Publicado: (2021)

Clinical challenges in the management of cardiac amyloidosis complicating aortic stenosis and coronary artery disease
por: Raval, Maharshi, et al.
Publicado: (2022)

Association between admission-blood-glucose-to-albumin ratio and clinical outcomes in patients with ST-elevation myocardial infarction undergoing percutaneous coronary intervention
por: Zhen, Cien, et al.
Publicado: (2023)

Marine Natural Products and Coronary Artery Disease
por: Liang, Bo, et al.
Publicado: (2021)

Colchicine for Coronary Artery Disease: A Review
por: Chen, Tao, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_de8tr8epma3s9rbjb51s32q1dt